Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

StemCor CE marks MarrowMiner for collecting bone marrow

This article was originally published in Clinica

Executive Summary

StemCor Systems has CE marked its MarrowMiner device for sale in Europe. The minimally-invasive system, used for the collection of bone marrow from the pelvis, received US FDA 510(k) clearance in November 2007 (see Clinica No 1281, p 22). The MarrowMiner is designed to make marrow extraction faster, safer and more comfortable, and is used to collect marrow from healthy donors for transplantation, and from patients to be treated with their own marrow-derived cells. The Menlo Park, California company says it represents the next-generation technology for bone marrow harvesting – it removes marrow through a single entry site without general anaesthesia, unlike conventional methods which remove it via a needle inserted into multiple sites in the hip.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042175

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel